This inventor holds 3 USPTO granted patents. Top assignees: Genome Therapeutics Corporation, Collaborative Research, Inc.. Active years: 1987-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1987-1996
Title: The Innovative Contributions of Bernadette L Alford
Introduction
Bernadette L Alford is a notable inventor based in Ashland, MA (US). She has made significant contributions to the field of biotechnology, particularly in the area of recombinant DNA technology. With a total of 3 patents to her name, her work has had a profound impact on the production of enzymatic proteins.
Latest Patents
Alford's latest patents include groundbreaking methods for producing rennin, prorenin, and pre-prorennin. These patents focus on living cells that contain genetic material derived from recombinant DNA, enabling the expression of these important proteins. The processes she developed allow for the production of desired enzymatic proteins during cell growth in culture, showcasing her innovative approach to biotechnology.
Career Highlights
Throughout her career, Bernadette L Alford has worked with prominent companies in the biotechnology sector, including Genome Therapeutics Corporation and Collaborative Research, Inc. Her expertise in recombinant DNA technology has positioned her as a key figure in her field, contributing to advancements that benefit various applications in medicine and research.
Collaborations
Alford has collaborated with notable professionals in her field, including Jen-i Mao and Donald T Moir. These partnerships have further enhanced her research and development efforts, leading to significant advancements in biotechnology.
Conclusion
Bernadette L Alford's contributions to the field of biotechnology through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to influence the production of essential proteins, paving the way for future advancements in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile